小鼠造血细胞移植后同种异体T细胞反应需要细胞周期蛋白依赖性激酶5活性
该临床前小鼠移植物抗宿主病(GVHD)模型研究显示,同种异体造血细胞移植(allo-HCT)后早期靶器官中细胞周期蛋白依赖性激酶5(Cdk5)活性升高。供体Cdk5缺失的骨髓和T细胞移植显著减轻全身及靶器官GVHD严重程度,与T细胞向次级淋巴器官迁移减少、体内增殖降低及细胞因子产生减少相关,并涉及CCR7信号改变。药理学抑制Cdk5保留了无白血病生存。
要点
- 同种异体造血细胞移植后早期,靶器官中Cdk5活性升高。
- 供体Cdk5缺失的骨髓和T细胞移植显著减轻小鼠全身及靶器官GVHD严重程度。
- 药理学抑制Cdk5保留了无白血病生存,提示Cdk5是干预同种异体T细胞反应的重要新靶点。
核心结论
- Cdk5参与造血细胞移植后的同种异体T细胞反应,并可能成为治疗干预的重要新靶点。
研究设计与样本
- 采用已建立的临床前小鼠GVHD模型,使用来自胚胎第16.5天Cdk5+/+或Cdk5-/-胚胎的造血祖细胞生成嵌合小鼠(Cdk5+/+C或Cdk5-/-C),以分析Cdk5在GVHD中的作用,因种系Cdk5基因缺失具有胚胎致死性。
主要发现
- 同种异体造血细胞移植后早期,关键靶器官中Cdk5活性升高。
- 成年Cdk5-/-C小鼠的免疫表型与对照Cdk5+/+C小鼠相同。
- 移植供体Cdk5-/-C骨髓和T细胞显著减轻全身及靶器官GVHD的严重程度。
- 该表型归因于T细胞向次级淋巴器官(SLOs)迁移减少、这些器官内体内增殖降低以及GVHD发展过程中产生细胞因子的供体T细胞减少。
- Cdk5-/-T细胞功能缺陷与CCL19连接后CCR7信号改变相关,该受体:配体相互作用对T细胞迁移进入SLOs至关重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Molecular intermediates in T-cell activation pathways are crucial targets for the therapy and prevention of graft-versus-host disease (GVHD) following allogeneic hematopoietic cell transplantation (allo-HCT). We recently identified an essential role for cyclin-dependent kinase 5 (Cdk5) in T-cell activation and effector function, but the contribution of Cdk5 activity to the development of GVHD has not been explored. Using an established, preclinical, murine, GVHD model, we reveal that Cdk5 activity is increased in key target organs early after allo-HCT. We then generated chimeric mice (Cdk5+/+C or Cdk5-/-C) using hematopoietic progenitors from either embryonic day 16.5 Cdk5+/+ or Cdk5-/- embryos to enable analyses of the role of Cdk5 in GVHD, as germ line Cdk5 gene deletion is embryonically lethal. The immunophenotype of adult Cdk5-/-C mice is identical to control Cdk5+/+C mice. However, transplantation of donor Cdk5-/-C bone marrow and T cells dramatically reduced the severity of systemic and target organ GVHD. This phenotype is attributed to decreased T-cell migration to secondary lymphoid organs (SLOs), reduced in vivo proliferation within these organs, and fewer cytokine-producing donor T cells during GVHD development. Moreover, these defects in Cdk5-/- T-cell function are associated with altered CCR7 signaling following ligation by CCL19, a receptor:ligand interaction critical for T-cell migration into SLOs. Although Cdk5 activity in donor T cells contributed to graft-versus-tumor effects, pharmacologic inhibition of Cdk5 preserved leukemia-free survival. Collectively, our data implicate Cdk5 in allogeneic T-cell responses after HCT and as an important new target for therapeutic intervention.
引用
- Askew D, Pareek TK, Eid S, et al. Cyclin-dependent kinase 5 activity is required for allogeneic T-cell responses after hematopoietic cell transplantation in mice. Blood. 2016. PMID: 28064242. doi:10.1182/blood-2016-05-702738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。